One hundred years of schizophrenia: a meta-analysis of the outcome literature
1994/10/01 by James D. Hegarty, Ross J. Baldessarini, Mauricio Tohen +2 · 29 citations
Medicine · Arts and Humanities · #Schizophrenia research and treatment #Mental Health and Psychiatry #Dementia and Cognitive Impairment Research
paper · doi:10.1176/ajp.151.10.1409
Abstract
OBJECTIVE: This study was undertaken to assess the twentieth-century literature on outcome in schizophrenia for historical trends that might be associated with changes in diagnostic and therapeutic practice and to test the hypothesis that both improved biological treatment and changes in diagnostic criteria have influenced outcome. METHOD: Meta-analysis of the international literature on outcome in schizophrenia or dementia praecox from 1895 to 1992 identified 821 studies; 320 of these, with 51,800 subjects in 368 cohorts, met the inclusion criteria for the study. RESULTS: Only 40.2% of patients were considered improved after follow-ups averaging 5.6 years (range = 1-40). Outcome was significantly better when patients were diagnosed according to systems with broad criteria (46.5% were improved) or undefined criteria (41.0% were improved) rather than narrow criteria (27.3% were improved). The proportion of patients who improved increased significantly after mid-century (for 1956-1985 versus 1895-1955, 48.5% versus 35.4%), probably reflecting improved treatment as well as a broadened concept of schizophrenia. However, in the past decade, the average rate of favorable outcome has declined to 36.4%, perhaps reflecting the re-emergence of narrow diagnostic concepts. CONCLUSIONS: Overall, less than half of patients diagnosed with schizophrenia have shown substantial clinical improvement after follow-up averaging nearly 6 years. Despite considerable gains in improvement rates after mid-century, there has been a decline since the 1970s. These historical changes probably reflect improved treatment, shifts in diagnostic criteria, and selection bias related to changes in health care.
Cited by
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- “Why shouldn’t I expect a lot from life?” – a qualitative study of what facilitates long-term recovery in first-episode psychosis
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
- First-Episode Psychosis, Early Intervention, and Outcome: What Have We Learned?
- Rationale for the study of early intervention. [europepmc]
- Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment. [europepmc]
- The evolution of drug development in schizophrenia: past issues and future opportunities. [europepmc]
- Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. [europepmc]
- Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. [europepmc]
- Research in people with psychosis risk syndrome: a review of the current evidence and future directions. [europepmc]
- Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. [europepmc]
- Key functional circuitry altered in schizophrenia involves parietal regions associated with sense of self. [europepmc]
- Recovery and severe mental illness: description and analysis. [europepmc]
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. [europepmc]
- Cognition in schizophrenia: Past, present, and future. [europepmc]
- Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity. [europepmc]
- The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. [europepmc]
- Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II). [europepmc]
- Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. [europepmc]
- Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. [europepmc]
- Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up. [europepmc]
- The iHOPE-20 study: Relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis. [europepmc]
- Longitudinal trajectory of early functional recovery in patients with first episode psychosis. [europepmc]
- Nonsocial and social cognition in schizophrenia: current evidence and future directions. [europepmc]
- The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review. [europepmc]
- Schizophrenia outcomes in the 21st century: A systematic review. [europepmc]
- Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis. [europepmc]
- The Lost Social Context of Recovery Psychiatrization of a Social Process. [europepmc]
- The effects of early and sustained intervention on the long-term morbidity of schizophrenia. [europepmc]
Related